FDA
The union for managers and professionals in public service
Home  >  Topic Search Results

Topic Search Results

Showing articles tagged with: Lucille Thirlby
 
pensions-555

The government has decided to withdraw regulations to cap exit payments in the public sector at £95k. Assistant General Secretary Lucille Thirlby explains what this means for members.

17 February 2021 | By Lucille Thirlby
Analysis/comment
pensions-555

Assistant General Secretary Lucille Thirlby explains the latest civil service pensions news and shares a Q&A on the impact on McCloud and Sargeant Judgements.

25 November 2019 | By Lucille Thirlby
News

FDA Assistant General Secretary Lucille Thirlby has written to Rupert McNeil – the Government Chief People Officer – to ask a new pension policy be extended to senior civil servants.

27 August 2019
News

FDA Assistant General Secretary Lucille Thirlby explained that while doctors will be granted greater freedom with pension tax contributions, senior civil servants and NHS managers have been left behind.

07 August 2019
FDA in the news
pensions-555

Assistant General Secretary discusses the latest on same sex couples' survivor benefits, the McCloud and Sergeant judgement, and civil service pensioners' overpayment letters.

25 July 2019 | By Lucille Thirlby
News
pensions-555

Assistant General Secretary Lucille Thirlby discusses the latest developments in the world of civil service pensions.

28 June 2019 | By Lucille Thirlby
News

"The pressure of workload is not being dealt with quickly enough within departments, and without a genuine resolve to reduce the causes of stress employees will continue to need to take sick leave to recover," said FDA AGS Lucille Thirlby.

31 May 2019
FDA in the news

General Secretary Dave Penman warns against a "race to the bottom" in public sector pay.

01 March 2019
News
Lucille-555

"The Treasury approach, yet again, seeks to crack a nut with a sledgehammer," says Assistant General Secretary Lucille Thirlby.

01 February 2019
News
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA